Average Co-Inventor Count = 5.82
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novo Nordisk A/s (74 from 1,772 patents)
2. Novo Nordiskals (1 from 10 patents)
3. Novo Nordick A/s (1 from 6 patents)
4. Noro Nordisk A/s (1 from 5 patents)
5. Noyo Nordisk Pharmaceuticals, Inc. (1 from 2 patents)
6. Novo Nordish A/s (1 from 1 patent)
79 patents:
1. 12152063 - Insulin analogues and uses thereof
2. 12122818 - Insulin analogues and uses thereof
3. 12077561 - CNP compounds
4. 11649269 - Bifunctional compounds comprising insulin peptides and EGF(A) peptides
5. 11498951 - Insulin analogues and uses thereof
6. 11471537 - Oligomer extended insulin-Fc conjugates
7. 11352406 - Insulin derivatives and the medical uses hereof
8. 10259856 - Protease stabilized acylated insulin analogues
9. 10040839 - Insulin derivatives and the medical uses hereof
10. 9896496 - Derivative of an insulin analogue
11. 9688737 - Protease stabilized acylated insulin analogues
12. 9512195 - Insulin derivatives containing additional disulfide bonds
13. RE46170 - Insulin derivatives
14. 9260503 - Multi-substituted insulins
15. 9242011 - Insulin albumin conjugates